Romy L.S. Mesman

<i>BRCA2</i> Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

Hermela Shimelis, Romy L.S. Mesman, Catharina Von Nicolai et al. · Cancer Research · 2017 · 90 citations · Full text

The functional impact of variants of uncertain significance in BRCA2

Romy L.S. Mesman, Fabienne M.G.R. Calléja, Giel Hendriks et al. · Genetics in Medicine · 2018 · 80 citations · Full text

Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2

Romy L.S. Mesman, Fabienne M.G.R. Calléja, Miguel de la Hoya et al. · Genetics in Medicine · 2020 · 36 citations · Full text

Skipping Nonsense to Maintain Function: The Paradigm of <i>BRCA2</i> Exon 12

Laëtitia Meulemans, Romy L.S. Mesman, Sandrine M. Caputo et al. · Cancer Research · 2020 · 31 citations

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

Hermela Shimelis, Romy L.S. Mesman, Catharina Von Nicolai et al. · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · 2017 · 15 citations · Full text